ESCMID aims to foster the next generation of leaders in the fields of infectious diseases and clinical microbiology. Effective leadership is essential in today’s fast-evolving healthcare landscape and strong leadership drives innovation, enhances team performance, and improves patient outcomes.

You can explore a range of expert-led workshops focused on your professional development. Currently there are two stand out courses available for registration:

• Lead with Impact: Fostering Collaboration & Navigating Complexity
  This course helps you build stronger teams through effective collaboration and teaches strategies to navigate challenges with confidence.
• Empowered: Female Leadership - Fostering Collaboration & Navigating Complexity
  Designed to support female leaders, this course addresses unique leadership challenges and empowers women to navigate complexity confidently while building strong, collaborative teams.
  
  

Explore these courses and more at the new ESCMID Leadership Hub.

Science and Research

To better address the important topic of vaccines in an overarching role within the Society, ESCMID is creating a brand-new Vaccine Subcommittee. We are now looking for a director who will be responsible for establishing this new subcommittee including defining the strategic directives. Interested persons can review the call document on our website now and apply before 31 August 2025.

The latest edition of the Epi Alert has just been released. The highlights from this week are an update on local transmission of Chikungunya in France, Polio resurgence risks, a recent death from Crimean-Congo Haemorrhagic Fever, and Scrub typhus emerging in Nepal.

Education

In high-resistance endemic settings, difficult-to-treat infections are not just clinical challenges - they are urgent public health threats. This ESCMID online course is designed specifically to empower professionals with the knowledge and practical tools to develop and lead antimicrobial stewardship programmes tailored to their local realities. Through this interactive course, participants will gain essential insights and strategies to combat antimicrobial resistance effectively, optimise patient care, and safeguard antibiotic efficacy for the future.

This course is part of the ESCMID AMS Certificate Programme and has a few spots available for extra participants.

The landscape of treating drug-resistant tuberculosis is evolving rapidly with new drugs and regimens. However, the diagnostic pipeline is struggling to keep pace. The World Health Organization has recently endorsed targeted Next Generation Sequencing as a molecular tool for obtaining rapid genotypic data to guide clinical management. Understanding its potential and limitations is crucial for effective implementation.

Register today for this on-site ESCMID course!

Congress and Events

The Abstract Book from ESCMID Global 2025 is now published in CMI Communications. The Abstract Book includes all submitted abstracts that were selected for the scientific programme as a poster or oral presentation, marking over 5K abstracts! With a DOI, you can now formally cite your work presented at ESCMID Global 2025.

Guidelines & Journals

WHO launched its first-ever guideline on meningitis diagnosis and management in April this year. In this episode of Communicable, hosts Emily McDonald and Marc Bonten are joined by two experts directly involved in creating the guideline, Lorenzo Pezzoli and Nicolò Binello of WHO, as well as Jacob Bodilsen, the Chair of ESCMID’s Study Group for Infectious Diseases of the Brain (ESGIB). The guests offer a firsthand look behind the guideline’s development, review key recommendations for diagnosis and treatment, and discuss how these fit into various clinical settings.

Acquisition and clearance of enteric pathogens in children under 5 years of age in Kigali and Musanze, Rwanda, 2022: A longitudinal cohort study

Re: Refining scores for non-invasive diagnosis of PCP by Soman et al

Ecraid panel discussion on adaptive trials: from theory to practice - 10 July 2025

EMA has released for public consultation a Concept paper on the new reflection paper on the clinical investigation of medicinal products for the treatment of systemic sclerosis

EMA has released for public consultation the draft revision of chapter 9 of the Guideline on epidemiological data on blood transmissible infections